Seer Inc (SEER) - Total Assets
Based on the latest financial reports, Seer Inc (SEER) holds total assets worth $308.61 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Seer Inc (SEER) net assets for net asset value and shareholders' equity analysis.
Seer Inc - Total Assets Trend (2018–2024)
This chart illustrates how Seer Inc's total assets have evolved over time, based on quarterly financial data.
Seer Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Seer Inc's total assets of $308.61 Million consist of 69.1% current assets and 30.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 11.1% |
| Accounts Receivable | $6.23 Million | 1.7% |
| Inventory | $7.44 Million | 2.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2024)
This chart illustrates how Seer Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Seer Inc worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Seer Inc's current assets represent 69.1% of total assets in 2024, a decrease from 92.6% in 2018.
- Cash Position: Cash and equivalents constituted 11.1% of total assets in 2024, down from 91.9% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is inventory at 2.0% of total assets.
Seer Inc Competitors by Total Assets
Key competitors of Seer Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fortress Biotech Inc
NASDAQ:FBIO
|
USA | $185.55 Million |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $261.73 Million |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
USA | $1.08 Billion |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
|
China | CN¥16.55 Billion |
|
BrightGene Bio Medical Technology C
SHG:688166
|
China | CN¥5.38 Billion |
|
BioArctic AB (publ)
ST:BIOA-B
|
Sweden | Skr2.60 Billion |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Seer Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 14.25 | 18.36 | 53.51 |
| Quick Ratio | 13.71 | 17.88 | 53.44 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $199.32 Million | $249.72 Million | $425.03 Million |
Seer Inc - Advanced Valuation Insights
This section examines the relationship between Seer Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.42 |
| Latest Market Cap to Assets Ratio | 0.31 |
| Asset Growth Rate (YoY) | -16.0% |
| Total Assets | $366.60 Million |
| Market Capitalization | $113.63 Million USD |
Valuation Analysis
Below Book Valuation: The market values Seer Inc's assets below their book value (0.31x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Seer Inc's assets decreased by 16.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Seer Inc (2018–2024)
The table below shows the annual total assets of Seer Inc from 2018 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $366.60 Million | -15.97% |
| 2023-12-31 | $436.27 Million | -10.59% |
| 2022-12-31 | $487.93 Million | -9.50% |
| 2021-12-31 | $539.14 Million | +21.89% |
| 2020-12-31 | $442.32 Million | +374.41% |
| 2019-12-31 | $93.24 Million | +176.70% |
| 2018-12-31 | $33.70 Million | -- |
About Seer Inc
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab fo… Read more